- トップ
- 研究業績
- Kurita N, Sakamoto T, Kato T, Kusakabe M, Yokoyama Y, Nishikii H, Sakata-Yanagimoto M, Obara N, Hasegawa Y, Chiba S. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide. Ann Hematol 100(5):1295-1301, May, 2021 (doi: 10.1007/s00277-021-04439-6.) Epub Feb 12, 2021
Kurita N, Sakamoto T, Kato T, Kusakabe M, Yokoyama Y, Nishikii H, Sakata-Yanagimoto M, Obara N, Hasegawa Y, Chiba S. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide. Ann Hematol 100(5):1295-1301, May, 2021 (doi: 10.1007/s00277-021-04439-6.) Epub Feb 12, 2021
2022/04/18
- 研究業績
- Kurita N, Sakamoto T, Kato T, Kusakabe M, Yokoyama Y, Nishikii H, Sakata-Yanagimoto M, Obara N, Hasegawa Y, Chiba S. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide. Ann Hematol 100(5):1295-1301, May, 2021 (doi: 10.1007/s00277-021-04439-6.) Epub Feb 12, 2021
« Bernard E, Nannya Y, Hasserjian RP, Devlin SM, Tuechler H, Medina-M... | Sakata-Yanagimoto M, Fukumoto K, Karube K, Chiba S. Molecular unde... »
